Antigenic characterization of recombinant, lymphoblastoid, and leukocyte IFN-α by monoclonal antibodies

Journal of Interferon and Cytokine Research

Volumn 19, Issue 4, 1999, Pages 319-326

  Viscomi, Giuseppe C ^a   Antonelli, G ^b   Bruno, C ^a   Scapol, L ^a   Malavasi, F ^c   Funaro, A ^c   Simeoni, E ^d   Pestka, S ^e,f   De Pisa, F ^g   Dianzani, F ^d  

^a Alfa Wassermann SpA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^f RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^g UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; MONOCLONAL ANTIBODY;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANTIGENICITY; ARTICLE; BONE MARROW CELL; CROSS REACTION; GENETIC RECOMBINATION; IMMUNOREACTIVITY; LYMPHOBLASTOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECOMBINANT DNA TECHNOLOGY; VIRUS INDUCTION; VIRUS NEUTRALIZATION;

ANIMALIA;

EID: 0032951170     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099314018     Document Type: Article

References (72)

1. BARON, S., COPPENHAVER, D.H., DIANZANI, F., FLEISHMMANN, W.R., JR., HUGHES, T.K., JR., KIMPEL, G.R., NIESEL, D.W., STANTON, G.J., and TYRING, S.K. (eds.) (1992). Interferon, Principles and Medical Applications. Galveston, TX: The University of Texas Medical Branch of Galveston, Department of Microbiology.
2. VISCOMI, G.G., GRIMALDI, M., PALAZZINI, E., and SILVESTRI, S. (1995). Human leukocyte interferon alpha: structure, pharmacology, and therapeutic application. Med. Res. Rev. 15, 445-478.
3. PESTKA, S., and TROTTA, P.P. (eds.) (1997). Recombinant alfa-interferon from naturally occurring genes. Semin. Oncol. 24(Suppl. 9).
4. CANTELL, K., HIRVONEN, S., KAUPPINEN, H.-L., and MYLLYLA, G. (1981). Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods Enzymol. 78, 29-38.
5. FINTER, N.B. (1981-1982). Large scale production of human interferon from lymphoblastoid cells. Tex. Rep. Biol. Med. 41, 175-178.
6. PESTKA, S. (1983). The human interferons - from protein purification and sequence to cloning and expression in bacteria: before, between, and beyond. Arch. Biochem. Biophys. 221, 1-37.
7. HERON, I., HOKLAND, M., and BERG, K. (1983). 13 native human interferon-alpha species assessed for immunoregulatory properties. J. Interferon Res. 3, 231-239.
8. RUBINSTEIN, M., LEVY, W.P., MOSCHERA, J.A., LAI, C-Y, HERSHBERG, R.D., BARTLETT, R.T., and PESTKA, S. (1981). Human leukocyte Interferon: isolation and characterization of several molecular forms. Arch. Biochem. Biophys. 210, 307-318.
9. PRAMANIK, B.N., TSARBOPOULOS, A., LABDON, J.E., TROTTA, P.P., and NAGABUDHUSHAN, T.L. (1991). Structural analysis of biologically active peptides and recombinant proteins and their modified counterparts by mass spectrometry. J. Chromatogr. 562, 377-389.
10. ZOON, K.C., MILLER. D., BEKISZ, I., ZUR NEDDEN, D., ENTERLINE, J.C., NGUYEN, N.Y., and HU, R.-Q. (1992). Purification and characterization of multiple components of human lymphoblastoid interferon-α. J. Biol. Chem. 267, 15210-15216.
11. 11 1): comparison with other human interferons. J. Gen. Virol. 68, 1669-1676.
12. HENCO, H., BROSIUS, J., FUJISAWA, A., FUJISAWA, J.-I., HAYNES, J.R., HOCHSTADT, J., KOVACIC, T., PASEK, M., SCHAMBOCK, A., SCHMID, J., NAGATA, S., and WEISSMANN, C. (1985). Structural relationship of human interferon alpha genes and pseudogenes. J. Mol. Biol. 185, 227-260.
13. PESTKA, S. (1997). The human interferon alpha species and hybrid proteins. Semin. Oncol. 24(Suppl. 9), 4-17.
14. LABDON, J.E., GIBSON, K.D., SUN, S., and PESTKA, S. (1984). Some species of human leukocyte interferon are glycosylated. Arch. Biochem. Biophys. 232, 422-426.
15. ADOLF, G.R., KALSNER, I., AHORN, H., MAURER-FOGY, I., and CANTELL, K. (1991). Natural human interferon alpha2 is glycosylated. Biochem. J. 276, 511-518.
16. SHIRONO, H., KOGA, J., UEMURA, H., and MATSUO, A. (1994), Identification of glycosylated subtypes of interferon-alpha produced by human leukocytes. Biosci. Biotechnol. Biochem. 58, 1714-1715.
17. HOBBS, D.S., MOSCHERA, J.A., LEVY, W.P., and PESTKA, S. (1981). Purification of human leukocyte interferon produced in a culture of human granulocytes. Methods Enzymol. 78, 472-481.
18. HOBBS, D.S., and PESTKA, S. (1982). Purification and characterization of interferons from a continuous myeloblastic cell line. J. Biol. Chem. 257, 4071-4076.
19. QUESADA, J.R., RIOS, A., TROWN, P., and GUTTERMAN, J.V. (1985). Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. J. Clin. Oncol. 3, 1522-1528.
20. ITRI, L.M., SHERMAN, M.I., PALLERONI, V., EVANS, L.M., TRAN, L.L., CAMPION, M., and CHIZZONITE, R. (1989). Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant imterferon-α2. J. Interferon Res. 9, S9-S15.
21. von WUSSOW, P., PRALLE, H., HOCHKEPPEL, H.K., JAKSCHIES, D., SONNEN, S., SCHMIDT, H., MULLER-ROSENAU, D., FRANKE, M., HAFERLACH, T., ZWINGER, T., RAPP, U., and DEICHER, H. (1991). Effective natural interferon-α therapy in recombinant interferon-α-resistant patients with hairy cell leukemia. Blood 78, 38-43.
22. ANTONELLI, G., CURRENTI, M., TURRIZIANI, O., RIVA, E., and DIANZANI, F. (1992). Relative frequency of nonneutralizing antibodies to interferon (IFN) in different IFNalpha preparations. J. Infect. Dis. 165, 593-594.
23. PRUMMER, O. (1993). Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant-interferon-alpha-2a in an adjuvant multicenter trial. Cancer 71, 1828-1834.
24. CORBILLET, V., CELERIER, P., LEBON. P., LITOUX. P., and DRENO, B. (1995). Développement d'anticorps anti-interféron au cours du traitement d'affections cutanées par interféron alpha 2a recombinant à faibles doses. Ann. Med. Interne 146, 399-403.
25. LOK, A.S.F., LAI, C.L., and LEUNG, E.K.-Y. (1990). Interferon antibodies may negate the antiviral effects of recombinant alphainterferon treatment in patients with chronic hepatitis B virus infection. Hepatology 12, 1266-1270.
26. MILELLA, M., ANTONELLI, G., SANTANTONIO, T., CURRENTI, M., MONNO, L., MARIANO, N., ANGARANO, G., DIANZANI, P., and PASTORE, G. (1993). Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection. Liver 13, 146-150.
27. GIANNELLI, G., ANTONELLI, G., FERA, G., DEL VECCHIO, S., RIVA, E., BROCCIA, C., SCHIRALDI, O., and DIANZANI, F. (1994). Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C. Clin. Exp. Immunol. 97, 4-9.
28. OBERG, K.E. (1994). Autoimmunity and antibodies to interferons in patients with carcinoid tumors. Clinical consequences. J. Interferon Res. 14, 215-216.
29. STEIS, R.G., and LONGO, D.L. (1994). Clinical relevance of recombinant interferon-alpha-2a antibodies in patients with hairy cell leukemia. J. Interferon Res. 14, 207-209.
30. MERUP, M, ENGMAN, K., and PAUL, C. (1994). Interferon antibodies in thrombocythemia. J. Interferon Res. 14, 187-189.
31. TORNEBOHM-ROCHE, E., MERUP, M., LOCKNER, D., and PAUL, C. (1994), Alpha-2a interferon therapy and antibody formation in patients with essential thrombocythemia and polycythemia vera with thrombocytosis. Am. J. Hematol. 48, 163-167.
32. ROFFI, L., COLLOREDO MELS, G., ANTONELLI, G., BELLATI, G., PANIZZUTI, F., PIPERNO-APOZZI, M., RAVIZZA, D., ANGELI, G., DIANZANI, F., and MANCIA, G. (1995). Breakthrough during recombinant al fa-interferon therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and management. Hepatology 21, 645-649.
33. RAJAN, O.P., SEIFERT, B., PRUMMER, O., JOLLERJEMELKA, H.I., BURG, G., and DUMMER, R. (1996). Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha2a combined with acitretin or PUVA. Arch. Dermatol. Res. 288, 543-548.
34. RUSSO, D., CANDONI, A., ZUFFA, E., MINISINI, R., SILVESTRI, F., FANIN, R., ZAJA, F., MARTINELLI, G., TURA, S., BOTTA, and BACCARANI, M. (1996). Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph(+) chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha. Br. J. Haematol. 94, 300-305.
35. SIMEONI, E., DIANZANI, F., VISCOMI, G., DE PISA F., COLIZZI, V., ARTINI, M., GIANNELLI, G., and ANTONELLI, G. (1997). Clinical relevance of antibodies to interferon in hepatitis C patients. Pharm. Sci. 3, 43-48.
36. BRAND, C.M., and LEADBEATER, L. (1994). Specificities of therapy-induced anti-interferon-alpha antibodies. J. Interferon Res. 14, 201-203.
37. NOLTE, K.U., JAKSCHIES, D., PESTKA, S., and VON WUSSOW, P. (1994). Different specificities of SLE-derived and therapy-induced interferon-alpha antibodies. J. Interferon Res. 14, 197-199.
38. BRAND, C.M., LEADBEATER, L., BELLATI, G., MAROTTA, F., and IDEO, G. (1993). Antibodies developing against a single recombinant interferon protein may neutralize other interferon-α subtypes. J. Interferon Res. 13, 121-125.
39. VON WUSSOW, P., PRALLE, H., HOCHKEPPEL, H.K., JAKSCHIES, D., SONNEN, S., SCHMIDT. H., MULLERROSENAU, D., FRANKE, M., HAFERLACH, T., ZWINGER, T., RAPP, U., and DEICHER, H. (1991). Effective natural interferon-α therapy in recombinant interferon-α-resistant patients with hairy cell leukemia. Blood 78, 38-43.
40. MERUP, M., TORNEBOHM-ROCHE, E., ENGMAN, K., and PAUL, C. (1994). Human leukocyte interferon-alpha therpay can induce a second response in treatment of thrombocytosis in patients with neutralising antibodies to recombinant interferon-alpha2a. Eur. J. Cancer 30, 1729-1730.
41. MILELLA, M., ANTONELLI, G., SANTANTONIO, T., GIANNELLI, G., CURRENTI, M., MONNO, L, TURRIZIANI, O., PASTORE, G., and DIANZANI, F. (1995). Treatment with natural IFN of hepatitis C patients with or without antibodies to recombinant IFN. Hepatogastroenterology 42, 201-204.
42. TEFFERI, A., and GRENDHAL, D.C. (1996). Natural leukocyte interferon-α therapy in patients with chronic granulocytic leukemia who have antibody-mediated resistance to treatment with recombinant interferon-α. Am. J. Hematol. 52, 231-233.
43. AGUET, M., SALGAM, P., GUTTE, B., and ARNHEITER, H. (1985). A crystalline synthetic peptide representing the epitope of a monoclonal antibody raised against synthetic interferon-α fragment 11.166, Eur. J. Biochem. 146, 689-691.
44. TROWN, P.W., HEIMER, E.P., FELIX, A.M., and BOHOSLAWEC, O. (1985). Localization of the epitopes for binding of the monoclonal antibodies LI-1 and LI-8 to leukocyte interferons. Tn: The Biology of the Interferon System. H. Kirchner, H. and H. Schellenkens (eds.) Amsterdam: Elsevier, pp. 69-76.
45. MEAGER, A., and BERG, K. (1986). Epitope localization of a monoclonal antibody, LO-22, with broad specificity for interferon-α subtypes. J. Interferon Res. 6, 729-736.
46. ALEXENKO, A.P., IZTOVA, L.S., KOSTROV, S.V., and STRONGIN, A.Y.A. (1991). Mapping of an epitope of human leukocyte interferon A which is recognized by the murine monoclonal antibody NK2. Biomed. Sci. 2, 403-409.
47. ANDERSSON, G., LUNDGREN, E., and EKRE, H.-P.T. (1991). Application of four anti-human IFN-α monoclonal antibodies for immunoassay and comparative analysis of natural IFNα mixtures. J. Interferon Res. 11, 53-60.
48. KONTSEK, P., BORECKY, L., KONTSEKOVÀ, E., MÀCIKOVÀ, I., KOLCUNOVÀ, A., NOVÀK, M., and KRCHNAK, V. (1991). Mapping of two immunodominant structures of human interferon alpha 2c and their role in binding to cells. Mol. Immunol. 28, 1289-1297.
49. KONTSEK, P., BORECKY, L., NOVÀK, M., KONTSEKOVÀ, E., MÀCIKOVÀ, I., and KRCHNAK, V. (1991). Distinct effect of pH 2 on a common antigenic structure found in human interferons-α1 and -α2 in the region 30-35. J. Interferon Res. 11,327-332.
50. REDLICH, P.N., HOEPRICH, P.D., JR., COLBY, C.B., and GROSSBERG, S.E. (1991). Antibodies that neutralize human β interferon biological activity recognize a linear epitope: analysis by synthetic peptide mapping. Proc. Natl. Acad. Sci. USA 88, 4040-4044.
51. KANDEFER-SZERSZEN, M., and LUNDGREN, E. (1992). Three separate epitopes on human interferon-α variants defined by monoclonal antibodies and their role in the binding to receptors. Arch. Immunol. Ther. Exp. (Warsz) 40, 241-246.
52. KONTSEK, P., BORECKY, L., KONTSEKOVÀ, E., KOLCUNOVÀ, A., NOVÀK, M., ZAVYALOV, V.P., and MAIOROV, V.A. (1992). Immunodominant structures in the aminoterminal portion of human interferon α1. Mol. Immunol. 29, 863-870.
53. KARAYIANNI-VASCONCELOS, G., FUCHSBERGER, N., SKAMLOVA, Z., and KONTSEK, P. (1993). Comparison of antigenic properties of three interferon (IFN)-alpha 2 subvariants and establishment of a quantitative IFN-alpha 2 ELISA. Acta Virol. 37, 509-514.
54. KONTSEK, P., BORECKY, L., ZAVYALOV, V.P., and MAIOROV, A. (1993). Peptide-mapping of three neutralizing epitopes into predicted biologically active sites of human interferon-α2. Immunol. Lett. 35, 281-284.
55. WANG, L., HERTZOG, P.J., GALANIS, M., OVERALL, M.L., WAINE, G.J., and LINNANE, A.W. (1994). Structure-function analysis of human IFNalpha. Mapping of a conformational epitope by homologue scanning, J. Immunol. 152, 705-715.
56. ALKAN, S., HOCHKEPPEL, H., and KUETTEL, L. (1995). Epitope analysis by monoclonal antibodies of five human recombinant interferon a subtypes. In: The Biology of the Interferon System. H, Kirchner and H. Schellekens (eds.) Amsterdam: Elsevier, pp. 91-98.
57. STAEHELIN, T., HOBBS, D.S., KUNG, H.-K., and PESTKA, S. (1981). Purification and characterization of recombinant human leukocyte interferon (IFLrA) with monoclonal antibodies. J. Biol. Chem. 256, 9750-9754.
58. REHBERG, E., KELDER, B., HOAL, E.G., and PESTKA, S. (1982). Specific activities of recombinant and hybrid leukocyte interferons. J. Biol. Chem. 257, 11497-11502.
59. a. J. Interferon Res. 14, 223-226.
60. DIAZ, M.O., POMYKALA, H.M., BOHLANDER, S.K., MALTEPE, E., MALIK, K., BROWNSTEIN, B., and OLOPADE, O.I. (1994). Structure of the human type-1 interferon gene cluster determined from a YAC clone contig. Genomics 22, 540-552.
61. CAPOBIANCHI, M.R., MATTANA, P., MERCURI, F., CONCIATORI, G., AMEGLIO, F., ANKEL, H., and DIANZANI, F. (1992). Acid lability is not an intrinsic property of interferon-alpha induced by HIV-infected cells. J. Interferon Res. 12, 431-438.
62. KAWADE, Y. (1980). An analysis of neutralization reaction of interferon by antibody: a proposal on the expression of neutralization titer. J. Interferon Res. 1, 61-70.
63. LAEMMLI, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 277, 680-685.
64. FISH, E.N. (1992). Definition of receptor binding domains in interferon alfa. J. Interferon Res. 12, 257-266.
65. ATHERTON, E., and SHEPPARD, R.C. (1989). Fluorenylmethoxycarbonyl-polyamide solid phase peptide synthesis - general principles and development. In: Solid Phase Peptide Synthesis, a Practical Approach. E. Atherton and R.C. Sheppard (eds.) Oxford, New York, Tokyo: IRL Press, pp. 25-37.
66. SHEARER. M., TAYLOR-PAPADIMITRIOU, I., GRIFFIN, D., and B ALKWILL, F. (1984). Monoclonal antibodies that distinguish between subspecies of human interferon-alpha and that detect interferon oligomers. J. Immunol. 133, 3096-3101.
67. SHIRONO, H., ITO, C., and KOGA, J. (1990). Studies on subtype composition in natural leukocyte interferon preparations. J. Virol. Methods 27, 1-10.
68. EDGE, M.D., GAMBLE, R., MOORE, V.E., HOCKNEY, R.C., CARR, F.J., and FITTON, J.E. (1986). Interferon analogues from synthetic genes: an approach to protein structure-activity studies. In: Interferon 7. I. Gresser (ed.) New York: Academic Press, pp. 1-46.
69. KONTSEK, P. (1994). Human type I interferons: structure and function. Acta Virol. 38, 345-360.
70. HOCHULI, E. (1997). Interferon immunogenicity: technical evaluation of interferon-α2a. J. Interferon Res. 17, s15-s21.
71. PALLERONI, A.V., AGLIONE, A., LABOW, M., BRUNDA, M.J., PESTKA, S., SINIGAGLIA, F., GAROTTA, G., ALSENZ, J., and BRAUN, A. (1997). Interferon immunogenicity: preclinical evaluation of interferon-α2a. J. Interferon Res. 17, s23-s27.
72. DIANZANI, F., and PESTKA, S. (eds.) (1997). A review of interferon immunogenicity. J. Interferon Cytokine Res. 17(Suppl. 1).